Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parman

Showing results (91-100 of 316) with videos related to

Pageof 32
Sort By:
Genes|July 2, 2020
Four Individuals with a Homozygous Mutation in Exon 1f of the <i>PLEC</i> Gene and Associated Myasthenic FeaturesMagdalena Mroczek, Hacer Durmus, Ana Töpf, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoinP M Kim, L M Winn, T Parman, et al.
Ideggyogyaszati Szemle|December 5, 2023
Pembrolizumab-induced peripheral nervous system damage: A combination of myositis/ myasthenia overlap syndrome and motor axonal polyneuropathyÇakar Arman, Kamaci Ibrahim, Orhan Kocasoy Elif, et al.
Brain Communications|January 26, 2024
Novel and nano-rare genetic causes of paediatric-onset motor neuronopathiesArman Cakar, Reza Maroofian, Yesim Parman, et al.
Human Immunology|May 25, 2006
HLA-DQ polymorphism in Turkish patients with myasthenia gravisGüher Saruhan-Direskeneli, Aylin Kiliç, Yeşim Parman, et al.
Clinical & Translational Immunology|June 23, 2026
Effect of CXCR5, PD-1 and ICOS on B-cell responses and relevance to myasthenia gravisMerve Çebi, Arman Çakar, Hacer Durmuş, et al.
Clinical EEG (Electroencephalography)|December 1, 1999
Eye closure related spike and wave discharges: clinical and syndromic associationsB Baykan-Kurt, A Gökyiğit, Y Parman, et al.
Scottish Medical Journal|July 1, 1975
Proceedings: Cephazolin in obstetricsW T Hannay, F Sharp, M G Parman, et al.
Lancet (London, England)|September 5, 1987
Detection of activated lymphocytes in endocrine pancreas of BB/W rats by injection of 123I-interleukin-2: an early sign of type 1 diabetesA Signore, A Parman, P Pozzilli, et al.
Experimental and Clinical Endocrinology|August 1, 1987
Labelling of interleukin-2 (IL-2) with 123-iodine with retention of its capacity to bind to activated lymphocytesA Signore, P C Beverley, A Parman, et al.
Pageof 32

Showing results (91-100 of 316) with videos related to

Sort By:
Pageof 32
Genes|July 2, 2020
Four Individuals with a Homozygous Mutation in Exon 1f of the <i>PLEC</i> Gene and Associated Myasthenic FeaturesMagdalena Mroczek, Hacer Durmus, Ana Töpf, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoinP M Kim, L M Winn, T Parman, et al.
Ideggyogyaszati Szemle|December 5, 2023
Pembrolizumab-induced peripheral nervous system damage: A combination of myositis/ myasthenia overlap syndrome and motor axonal polyneuropathyÇakar Arman, Kamaci Ibrahim, Orhan Kocasoy Elif, et al.
Brain Communications|January 26, 2024
Novel and nano-rare genetic causes of paediatric-onset motor neuronopathiesArman Cakar, Reza Maroofian, Yesim Parman, et al.
Human Immunology|May 25, 2006
HLA-DQ polymorphism in Turkish patients with myasthenia gravisGüher Saruhan-Direskeneli, Aylin Kiliç, Yeşim Parman, et al.
Clinical & Translational Immunology|June 23, 2026
Effect of CXCR5, PD-1 and ICOS on B-cell responses and relevance to myasthenia gravisMerve Çebi, Arman Çakar, Hacer Durmuş, et al.
Clinical EEG (Electroencephalography)|December 1, 1999
Eye closure related spike and wave discharges: clinical and syndromic associationsB Baykan-Kurt, A Gökyiğit, Y Parman, et al.
Scottish Medical Journal|July 1, 1975
Proceedings: Cephazolin in obstetricsW T Hannay, F Sharp, M G Parman, et al.
Lancet (London, England)|September 5, 1987
Detection of activated lymphocytes in endocrine pancreas of BB/W rats by injection of 123I-interleukin-2: an early sign of type 1 diabetesA Signore, A Parman, P Pozzilli, et al.
Experimental and Clinical Endocrinology|August 1, 1987
Labelling of interleukin-2 (IL-2) with 123-iodine with retention of its capacity to bind to activated lymphocytesA Signore, P C Beverley, A Parman, et al.
Pageof 32